Clinical comparison · Recovery
BPC-157 vs TB-500
BPC-157 and TB-500 are the two most-requested recovery peptides. BPC-157 shines for local injury and GI protocols; TB-500 covers systemic soft-tissue healing.
Attribute
BPC-157
TB-500
Mechanism
Angiogenic pentadecapeptide; VEGFR-2 signaling and fibroblast migration for soft-tissue repair.
Synthetic thymosin beta-4 fragment. G-actin sequestration, cell migration, anti-inflammatory cytokine profile.
Standard dosing
500 mcg SC twice daily loading, then once daily 4–6 weeks.
2–2.5 mg SC twice weekly loading, then 2 mg weekly maintenance.
Indications
- Tendonitis / tendinopathy
- Ligament sprains
- GI mucosal inflammation
- Tendon and ligament repair
- Muscle strains
- Chronic inflammation
Strengths
- Excellent GI + soft-tissue coverage
- Local injection near injury site possible
- Systemic reach for whole-body injury protocols
- Longer dosing interval
Cautions
- Compounded 503A only
- Pause 48h around surgery
- Avoid in active malignancy
- Higher per-dose cost than BPC-157
- Same malignancy caution
Choose BPC-157 when
Localized tendonitis, ligament injury, or a GI-lining protocol.
Wholesale BPC-157 →Choose TB-500 when
Diffuse or systemic soft-tissue injury, chronic inflammation, or endurance-athlete recovery.
Wholesale TB-500 →FAQs
- Can BPC-157 and TB-500 be stacked?
- Yes, and they commonly are. BPC-157 500 mcg SC daily + TB-500 2 mg SC twice weekly is the standard tendon stack.
- Which acts faster?
- BPC-157 typically shows symptomatic relief in 1–2 weeks; TB-500 acts more gradually over 4–6 weeks.